경제뉴스 bluebird bio's CHMP Response Lays Ground Work For Its First Gene Therapy Approval 투자를 통해서 배우는 인생 2019. 4. 12. 07:53 https://seekingalpha.com/article/4254073-bluebird-bios-chmp-response-lays-ground-work-first-gene-therapy-approval bluebird bio's CHMP Response Lays Ground Work For Its First Gene Therapy Approval bluebird bio's Zynteglo receives positive CHMP opinion for approval of Zynteglo to treat transfusion dependent beta-thalassemia patients. The European Commissio seekingalpha.com 저작자표시